RxDoctor Payments Data

Terri Page

Women's Health · Mechanicsville, VANPI 1770765067

Payments from drug & device makers

What this record shows

22 manufacturers reported payments, led by Pfizer at 44.1% of the total. Reporting peaked in 2022 at $1,483 and has fallen 80.2% since, to $294 in 2025. Among women's health clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,483in general payments, 2019–2025

Across 90 payments — averaging $27.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • AbbVie$295
  • Mayne Pharma Commercial LLC$212
  • Biogen$124
  • Sumitomo Pharma America, Inc.$104
  • Myovant Sciences Inc.$104
  • plus $548 from 16 others

What the payments were for

  • Consulting fees$1,08043%
  • Food & beverage$1,40357%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,483 in reported general payments places this provider in the 90th percentile of 188 women's health providers in Virginia.

See all women's health providers in Virginia

Medicare billing

Part B allowed, 2024
$14,280
Medicare patients
152
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol71$5,285
Estradiol (Twice Weekly)Estradiol17$2,064
ValacyclovirValacyclovir Hcl16$575
Metronidazole16$367
Medroxyprogesterone Acetate15$329
Nystatin28$268
Fluconazole37$180
Fluoxetine Hcl12$44

Paid to pharmacies, not to this prescriber.

Other women's health in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →